Clinical Trials
17 trialsNCT05864846 2026-04-27
EpiCom
Jazz Pharmaceuticals
Phase 4 Completed
NCT05059327 2025-06-04
Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC
Noema Pharma AG
Phase 2 Completed
NCT04595786 2025-03-04
STAMP
Beijing Tiantan Hospital
Phase NA Completed
NCT01977651 2024-12-06
UPWARD
Astellas Pharma Inc
Phase 4 Completed
NCT04497142 2024-08-05
Effect of Perampanel on Peritumoral Hyperexcitability in HGG
Dana-Farber Cancer Institute
Phase 1/2 Completed
NCT04430842 2023-01-18
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Quadriga Biosciences, Inc.
Phase 1 Completed
NCT02544763 2022-09-28
A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Jazz Pharmaceuticals
Phase 3 Completed
NCT02544750 2022-07-14
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Jazz Pharmaceuticals
Phase 3 Completed
NCT02881957 2022-06-15
Hypovitaminosis D in Neurocritical Patients
University of Utah
Phase 2/3 Completed
NCT03826056 2022-01-11
Neurology Inpatient Clinical Education Trial
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT02334722 2021-12-15
1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
University of Florida
Phase 4 Completed
NCT03650452 2021-02-18
ELEKTRA
Takeda
Phase 2 Completed
NCT00179517 2019-07-17
Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo
Beth Israel Deaconess Medical Center
Phase 2 Completed
NCT02363933 2018-04-27
Perampanel in Seizure Patients With Primary Glial Brain Tumors
Duke University
Phase 4 Completed
NCT01601314 2018-01-17
MAGNA
Fundacion Clinic per a la Recerca Biomédica
Phase 3 Completed
NCT00790400 2017-02-17
EXIST-2
Novartis
Phase 3 Completed
NCT00629889 2013-05-22
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors
Centre Hospitalier Universitaire Vaudois
Phase 2 Completed